Khaled Imam

Khaled Imam practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Khaled Imam's NPI, 1902865454, was assigned on March 22, 2006. Khaled Imam holds Michigan license 4301047866.

Khaled Imam's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Khaled Imam's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Khaled Imam is also affiliated with Corewell Health Farmington Hills Hospital. The medical group on file is Medical Education Associates. Dmand AI also links Khaled Imam to 2 more group practices and clinics, 2 skilled nursing facilities, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Khaled Imam practices, 7 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Khaled Imam's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Khaled Imam is licensed in Michigan.

CMS data shows 447 Medicare services from Khaled Imam across 3 procedure codes in 2024, for 160 Medicare patients. Medicare paid $38,710 for them.

CMS counts 160 Medicare patients who saw Khaled Imam in 2024. The largest group is 85 and over, with 73 patients. 75% of them have arthritis, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Khaled Imam's median patient age at 82, with 62% women.

In 2024, Khaled Imam wrote 2,668 Medicare Part D claims for 187 patients. 84% of them were for generic drugs. CMS names the drug for 2,145 of them, across 66 drugs with 11 or more claims each, at $116,286 in total drug cost. In 2023, CMS named 1,990 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Khaled Imam for performance year 2024, reported as part of a group. Khaled Imam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Khaled Imam, published from 2020 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Alzheimer Disease. Khaled Imam's most frequent co-authors are Michael E. Maddens, Ray O. Bahado-Singh, MD and Stacey Marie Ruff, DO.

CMS Open Payments shows 2 general payments to Khaled Imam from 2 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $65.